Status:
UNKNOWN
The Predictive Scores for Gastric Cancer in Gastric Intestinal Metaplasia (GIM) Patient: a Recommendation for Thai Population
Lead Sponsor:
King Chulalongkorn Memorial Hospital
Conditions:
Gastric Intestinal Metaplasia
Eligibility:
All Genders
Brief Summary
The predictive scores for gastric cancer in gastric intestinal metaplasia(GIM) patient: a recommendation for Thai population. Objective: To evaluate major risk factors for gastric cancer in gastric ...
Detailed Description
Study population and Sample size at Faculty of Medicine, Chulalongkorn University The patients who were diagnosed gastric intestinal metaplasia from 1997 to 2012 and then follow up for 5 years. Estima...
Eligibility Criteria
Inclusion
- All patients were diagnosed GIM
- All patients have to sign the consent form
Exclusion
- Previous gastric surgery including gastrectomy and bypass surgery
- Bleeding tendency including decompensated cirrhosis, chronic kidney disease and long-tem antiplatelets or anticoagulants
- HIV infection
- History of proton pump inhibitor use within 1 week
- History of antibiotic use within 4 weeks
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2017
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT01490541
Start Date
October 1 2011
End Date
October 1 2017
Last Update
June 25 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rapat Pittayanon
Bangkok, Bangkok, Thailand, 10330